Patents Assigned to National University Corporation Hokkaido University
-
Publication number: 20240238202Abstract: The present invention provides lipid nanoparticles that contain a pH-sensitive cationic lipid and a polyalkylene glycol-modified lipid. The pH-sensitive cationic lipid fraction of the total lipids that constitute the lipid nanoparticles is 10-25 mol %, the polyalkylene glycol-modified lipid fraction of the total lipids that constitute the lipid nanoparticles is 0.5-1.75 mol %, and the number average particle size of the lipid nanoparticles is at least 150 nm.Type: ApplicationFiled: May 19, 2022Publication date: July 18, 2024Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Yusuke Sato, Kosuke Sasaki, Hideyoshi Harashima
-
Patent number: 12037422Abstract: Disclosed is a gel material having a high water content and excellent mechanical properties. The gel material includes repeating units derived from the following monomers (A) and (B): (A) an anionic monomer containing a polymerizable carbon-carbon multiple bond and an aromatic ring, and (B) a cationic monomer containing a polymerizable carbon-carbon multiple bond and an aromatic ring. The gel material has a water content of 20% by mass to 95% by mass, a tensile elastic modulus of 9 MPa to 1000 MPa, and a tensile elongation at break of 50% to 5000%.Type: GrantFiled: August 27, 2019Date of Patent: July 16, 2024Assignees: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, TORAY INDUSTRIES, INC.Inventors: Jian Ping Gong, Takayuki Kurokawa, Honglei Guo, Takahiro Matsuda, Chengtao Yo
-
Publication number: 20240226341Abstract: A dispersion for an X-ray target in which gold nanoparticles and sodium alginate or a calcium phosphate-based bone reinforcing material are dispersed, in which the gold nanoparticles are in contact with the sodium alginate or the calcium phosphate-based bone reinforcing material.Type: ApplicationFiled: February 25, 2022Publication date: July 11, 2024Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Tetsu Yonezawa, Hiroki Shirato, Naoki Miyamoto
-
Patent number: 12017088Abstract: This radiotherapy device comprises: an X-ray irradiation device and an X-ray camera for detecting the position of a specific landmark present in an irradiation target; a storage unit which, with one from among a plurality of time-lapse three-dimensional CT images including the landmark and obtained beforehand during treatment planning used as a reference images, stores the relationship between the displacement of the landmark position from that in the reference image to that in another three-dimensional CT image, and the deformation of each of the sites in the other CT image, obtained by analysis thereof; and an image processing unit, a deformation amount evaluation unit, and a display unit, that estimate the deformation of each of the sites and reproduce the estimated three-dimensional CT image, according to the position of the landmark detected and the relationship stored by the storage unit.Type: GrantFiled: May 23, 2019Date of Patent: June 25, 2024Assignee: National University Corporation Hokkaido UniversityInventors: Naoki Miyamoto, Kikuo Umegaki, Shinichi Shimizu, Satoshi Tomioka, Seishin Takao
-
Patent number: 12013389Abstract: The present invention provides a method of evaluating pathological conditions of heart failure based on a new mechanism of action of heart failure, a method of evaluating a candidate compound for a heart failure treatment drug using the mechanism of action, and a pharmaceutical composition for treating or preventing heart failure using the mechanism of action. That is, the present invention provides a method of evaluating pathological conditions of heart failure including measuring an amount of succinyl-CoA in cardiomyocytes collected from a test animal, a respiratory capacity of mitochondrial complex II in peripheral blood mononuclear cells collected from the test animal or an amount of reactive oxygen species released from peripheral blood mononuclear cells collected from the test animal; and evaluating the onset of heart failure of the test animal or the severity of heart failure based on the obtained measurement values.Type: GrantFiled: June 28, 2019Date of Patent: June 18, 2024Assignee: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Shingo Takada, Satoshi Maekawa, Takashi Yokota, Ryosuke Shirakawa, Hisataka Sabe
-
Publication number: 20240188565Abstract: An object of the present invention is to provide an industrially easily available hatching factor on Globodera pallida larvae, a control agent and a control method using the same.Type: ApplicationFiled: January 27, 2022Publication date: June 13, 2024Applicants: NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION, NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, Nippon Soda Co., Ltd.Inventors: Atsuhiko KUSHIDA, Itaru SAKATA, Keiji TANINO, Kousuke KATO, Takuya ITABASHI, Jun KANAZAWA, Yuto IKEDA, Takashi KITAYAMA, Satoshi KOIZUMI, Yoko OSAWA, Tsutomu INOUE
-
Publication number: 20240189803Abstract: A catalyst structure for synthesis gas production is used to produce a synthesis gas that includes carbon monoxide and hydrogen. The structure includes a carrier with a porous structure that comprises a zeolite-type compound; first catalyst particles that contain at least one iron-group element selected from the group consisting of nickel, iron, and cobalt; and a second catalyst that contains at least one transition metal element with redox capacity. The carrier includes, inside thereof, mutually communicating passages; the first catalyst particles are present at least in the passages of the carrier; and the second catalyst is present at least in the interior or on an outer surface of the carrier.Type: ApplicationFiled: March 30, 2022Publication date: June 13, 2024Applicants: FURUKAWA ELECTRIC CO., LTD., NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Yuichiro BANBA, Masayuki FUKUSHIMA, Yuki KAWAMATA, Yuki IWANO, Tomohiko MORI, Takashi FUJIKAWA, Takao MASUDA, Yuta NAKASAKA, Takuya YOSHIKAWA
-
Publication number: 20240162435Abstract: The objective of the present invention is to provide a method for producing a layered composite metal oxide crystal material, which can be utilized as a positive electrode material for a lithium ion secondary battery or the like, in a milder condition, and methods for producing a positive electrode and a lithium ion secondary battery using the above method.Type: ApplicationFiled: March 17, 2022Publication date: May 16, 2024Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Masaki MATSUI, Rannosuke MAEDA
-
Publication number: 20240161280Abstract: A slide number estimation apparatus (2000) acquires a slide image (30). The slide image (30) an image of a specimen slide (20) obtained from a tissue piece (10) of a subject. The slide number estimation apparatus (2000) estimates the number of tumor cells included in a region of interest (22) of the specimen slide (20) corresponding to the obtained slide image (30) using the slide image (30). The slide number estimation apparatus (2000) estimates the number of the specimen slides (20) to be obtained from the tissue piece (10) for conducting a predetermined test based on the estimated number of tumor cells.Type: ApplicationFiled: February 1, 2022Publication date: May 16, 2024Applicants: NCE CORPORATION, NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Ayaka AMAKAWA, Maki SANO, Hokkaido HATANAKA, Yutaka HATANAKA
-
Publication number: 20240150853Abstract: The present invention provides a method for quantitatively detecting virus-derived RNA and/or DNA in an environmental sample or a fecal sample with high sensitivity, and a kit for quantitatively detecting virus-derived RNA and/or DNA in an environmental sample or a fecal sample with high sensitivity.Type: ApplicationFiled: February 25, 2022Publication date: May 9, 2024Applicants: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, Shionogi & Co., Ltd.Inventors: Masaaki KITAJIMA, Ryo IWAMOTO, Yusaku MASAGO, Shin HAYASE, Yuka KATAYAMA ADACHI
-
Patent number: 11977080Abstract: Disclosed is a method for acquiring information of a target polypeptide, comprising: acquiring a diffusion time of a fluorescently labeled target polypeptide and a diffusion time of each of a plurality of fluorescently labeled reference polypeptides by fluorescence correlation spectroscopy or fluorescence cross-correlation spectroscopy, and acquiring information on size of the fluorescently labeled target polypeptide from the diffusion time of the fluorescently labeled target polypeptide with reference to the diffusion times of the plurality of fluorescently labeled reference polypeptides, wherein information on size of each of the plurality of fluorescently labeled reference polypeptides is known, and the sizes of the plurality of reference polypeptides are different from each other.Type: GrantFiled: April 27, 2021Date of Patent: May 7, 2024Assignees: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, SYSMEX CORPORATIONInventors: Masataka Kinjo, Akshay Ganguly, Lausonia Ramaswamy
-
Patent number: 11972985Abstract: This complementary switch element includes: a first TFET having a first conductive channel; and a second TFET having a second conductive channel. Each of the first TFET and the second TFET includes: a group IV semiconductor substrate doped in a first conductive type; a nanowire which is formed of a group III-V compound semiconductor and is disposed on the group IV semiconductor substrate; a first electrode connected to the group IV semiconductor substrate; a second electrode connected to the nanowire; and a gate electrode. The nanowire includes a first area connected to the group IV semiconductor substrate and a second area doped in a second conductive type. In the first TFET, the second electrode is a source electrode, and the first electrode is a drain electrode. In the second TFET, the first electrode is a source electrode, and the second electrode is a drain electrode.Type: GrantFiled: December 25, 2019Date of Patent: April 30, 2024Assignee: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventor: Katsuhiro Tomioka
-
Publication number: 20240131202Abstract: A dispersion for an X-ray target in which gold nanoparticles and sodium alginate or a calcium phosphate-based bone reinforcing material are dispersed, in which the gold nanoparticles are in contact with the sodium alginate or the calcium phosphate-based bone reinforcing material.Type: ApplicationFiled: February 25, 2022Publication date: April 25, 2024Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Tetsu Yonezawa, Hiroki Shirato, Naoki Miyamoto
-
Patent number: 11966716Abstract: An information processing apparatus includes an annealing control unit, a spin interaction memory, a random number generation unit, and a spin state update unit and obtains a solution by using an Ising model. The annealing control unit controls an annealing step and a parameter of a temperature and a parameter of a self-action. The spin interaction memory stores the interaction coefficient of a spin. The random number generation unit generates a predetermined random number. The spin state update unit includes a spin buffer that stores values of a plurality of spins, an instantaneous magnetic field calculation unit that calculates instantaneous magnetic fields of the plurality of spins, a probability calculation unit that calculates update probabilities of the plurality of spins, and a spin state determination unit that updates the values of the spins based on the update probabilities and a random number.Type: GrantFiled: August 28, 2020Date of Patent: April 23, 2024Assignees: HITACHI, LTD, NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Normann Mertig, Takashi Takemoto, Shinya Takamaeda, Kasho Yamamoto, Masato Motomura, Akira Sakai, Hiroshi Teramoto
-
Publication number: 20240100099Abstract: Provided is a composition for promotion of the regeneration of the nucleus pulposus of an intervertebral disc, said composition comprising a low endotoxin monovalent metal salt of alginic acid and mesenchymal stem cells. In particular, the composition of the present invention promotes the regeneration of the nucleus pulposus of an intervertebral disc via activation of nucleus pulposus cells by human bone marrow-derived high-purity mesenchymal stem cells and/or differentiation of human bone marrow-derived high-purity mesenchymal stem cells into nucleus pulposus cells.Type: ApplicationFiled: January 28, 2022Publication date: March 28, 2024Applicants: National University Corporation Hokkaido University, PuREC Co., Ltd., Mochida Pharmaceutical Co., Ltd.Inventors: Hideki SUDO, Daisuke UKEBA, Katsuhisa YAMADA, Katsuro URA, Hisataka SUZUKI, Yumi IYOKU, Takashi SUYAMA
-
Publication number: 20240089093Abstract: An object is to prevent eavesdropping in quantum key distribution. A decoding unit decodes a quantum signal incident thereinto. A plurality of detect photons of the decoded quantum signal output from the decoding unit. A signal processing unit detects bits of the decoded quantum signal based on photon detection results of the plurality of detectors. A control unit perform switching processing by switching destinations to which two decoded quantum signals corresponding to one encoding basis are output between the plurality of detectors, and switching the bits detected by the signal processing unit based on the respective photon detection results of the plurality of detectors.Type: ApplicationFiled: January 24, 2022Publication date: March 14, 2024Applicants: NEC CORPORATION, NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY, NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, THE UNIVERSITY OF TOKYOInventors: Ken-ichiro YOSHINO, Mikio FUJIWARA, Akihisa TOMITA, Masato KOASHI, Masahiro TAKEOKA, Masahide SASAKI
-
Publication number: 20240076763Abstract: A heat-resistant alloy contains Y, a content of Ni is a content of Ni is 58.0 mass % or greater, a content of Cr is 20.0 mass % or greater and 23.0 mass % or less, a content of Mo is 8.0 mass % or greater and 10.0 mass % or less, a content of Nb is 3.15 mass % or greater and 4.15 mass % or less, a content of O is 0.002 mass % or greater and 0.1 mass % or less, and a ratio of a content of Y in terms of mass to a content of O in terms of mass is 0.5 or greater and 100 or less.Type: ApplicationFiled: October 27, 2023Publication date: March 7, 2024Applicants: TOKYO METROPOLITAN PUBLIC UNIVERSITY CORPORATION, NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Koji Kakehi, Shigenari Hayashi, Yen-Ling Kuo
-
Patent number: 11904185Abstract: A proton beam therapy system 1 includes an irradiation nozzle 25 for irradiating a target 31A with a particle beam, a proton beam irradiation control system 41 that controls the irradiation nozzle 25, a dose monitor 27B that measures an irradiation amount of the particle beam emitted to the target 31A, a position monitor 27A that measures a position of the particle beam emitted to the target 31A, and a dose distribution evaluation system during irradiation 55 that calculates a dose distribution of the particle beam emitted to the target 31A during irradiation. This system supports a medical staff to quickly and appropriately make an intervention determination for treatment such as discontinuation of particle therapy, a change in conditions thereof, or the like in the process of particle irradiation.Type: GrantFiled: November 15, 2019Date of Patent: February 20, 2024Assignees: HITACHI, LTD., NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Shusuke Hirayama, Rintarou Fujimoto, Masumi Umezawa, Yuusuke Fujii, Keiji Kobashi, Taeko Matsuura, Shinichi Shimizu
-
Publication number: 20240050477Abstract: The present invention provides a lipid nanoparticle and the like containing a pH-sensitive cationic lipid represented by formula (1) (in formula (1), R1 and R2 are each independently a straight-chain C10-14 alkyl group, a straight-chain C10-20 alkenyl group having one or two unsaturated bonds, or —CH(R5)(R6)(where R5 and R6 are each independently a straight-chain C5-10 alkyl group); p represents an integer of 3-8; and R3 and R4 are each independently a methyl group or an ethyl group].Type: ApplicationFiled: February 17, 2022Publication date: February 15, 2024Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Takashi Nakamura, Hideyoshi Harashima, Yusuke Sato, Koharu Yamada, Taisei Nakade
-
Publication number: 20240043476Abstract: The present invention provides a peptide that consists of an amino acid sequence with 20 or fewer residues containing at least one amino acid sequence selected from the group consisting of the amino acid sequence represented in SEQ ID NO: 1, the amino acid sequence represented in SEQ ID NO: 2 and the amino acid sequence represented in SEQ ID NO: 38, the peptide having an activity to inhibit proliferation of a tumor cell or having an activity to inhibit binding between an epidermal growth factor receptor and a signal-transducing adaptor family member-2 (STAP-2); a peptide with a cell-penetrating peptide added to a terminus of the above peptide with or without a linker sequence interposed between the cell-penetrating peptide and the terminus; and pharmaceutical compositions containing any of these peptides.Type: ApplicationFiled: August 18, 2021Publication date: February 8, 2024Applicant: National University Corporation Hokkaido UniversityInventors: Tadashi Matsuda, Kenji Oritani, Yuichi Kitai